98%
921
2 minutes
20
Background: The prevalence and severity of QT interval prolongation (long QT, LQT) in takotsubo syndrome (TS) is not well described.
Methods: This is a retrospective cohort study of all patients admitted in our Centre between January 2019 and December 2023 with confirmed TS. QT interval corrected for heart rate (QTc) (Bazzett formula) was measured manually in all available ECGs. Presence of other ECG abnormalities (T-wave inversion (TWI), ST segment elevation (STE), ST segment depression (STD)) were also recorded.
Results: Fifty-eight patients were included, all women (68 ± 11 years). Fifty-six patients (96.6 %) had classical, apical ballooning form of TS. Symptoms included chest pain (93.1 %), dyspnoea (10.3 %), and others (5.2 %). Triggers were present in 70.7 % of patients. Three-hundred-and-thirty ECGs were analysed. LQT was infrequent in the first 3 h after symptom onset (23.5 % of patients), and was only mild. However, between 24 and 48 h after symptom onset, 90.9 % of patients developed LQT, which was severe (≥500 ms) in 63.6 % of patients. LQT prevalence decreased afterwards but QTc did not return to normal in 40.0 % of patients, and remained severely prolonged in 11.4 % of patients beyond 96 h. ECG was normal in 40.5 % of patients in the first 6 h. TWI was the predominant ECG change, and its prevalence increased from 16.7 % within the first 6 h to 76.9 % after 7 days. STE was present in 31.4 % of patients in the first 96 h, but was rare in isolation. Isolated STD did not occur.
Conclusion: LQT is almost universally seen in patients with TS within the first 96 h after symptom onset, and is severe in the majority. ECGs abnormalities in TS are highly dynamic, but ECGs are frequently normal in the first 6 h after symptom onset. Patients should be monitored for at least 96 h after symptom onset, and until QTc falls below 500 ms.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jelectrocard.2024.153848 | DOI Listing |
Blood Press Monit
September 2025
Baishan Maternal and Child Health and Family Planning Service Center, Baishan City, Jilin Province, China.
Objective: This study investigated the relationship of maternal serum uric acid, cystatin C (CysC), and coagulation indices [international normalized ratio (INR) and fibrinogen (FIB)] during pregnancy with clinical features and prognosis of early-onset pre-eclampsia.
Methods: Patients with pre-eclampsia (n = 133) were retrospectively selected, with clinical features and maternal uric acid, CysC, INR, and FIB levels collected. The relationship between clinical features and maternal uric acid, CysC, INR, and FIB was analyzed by Pearson's and Spearman's analyses.
J Cardiovasc Electrophysiol
September 2025
City St George's University of London, London, UK.
Introduction: Etripamil is a fast-acting intranasally self-administered calcium-channel blocker developed for termination of paroxysmal supraventricular tachycardia (PSVT). Prior studies have demonstrated safety and efficacy of etripamil for PSVT termination following an initial medically supervised test dose during sinus rhythm. NODE-303 is an open-label, single-arm study that evaluated etripamil for multiple, at-home PSVT episodes, without test dose before first use.
View Article and Find Full Text PDFNeuroinflammation has emerged as a central and dynamic component of the pathophysiology underlying a wide range of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis. Far from being a secondary consequence of neuronal damage, inflammatory processes (mediated by microglia, astrocytes, peripheral immune cells, and associated molecular mediators) actively shape disease onset, progression, and symptomatology. This review synthesizes current knowledge on the cellular and molecular mechanisms that govern neuroinflammatory responses, emphasizing both shared and disease-specific pathways.
View Article and Find Full Text PDFCerebrovasc Dis Extra
August 2025
Introduction: Trousseau syndrome (TS) represents a significant vascular thromboembolic event in cancer patients and has progressively gained attention as a critical clinical concern in recent years. The aim of this study is to investigate the survival status and prognostic factors in patients with TS whose initial clinical manifestation was acute ischemic stroke (AIS).
Methods: A retrospective analysis was conducted on 24 TS patients hospitalized at the Affiliated Hospital of Jiangsu University between 2018 and 2024.
J Med Genet
September 2025
Department of Pediatrics, Danish Epilepsy Center, Dianalund, Denmark
Rare variants in , the gene encoding the GluA3 subunit of amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs), are associated with defects in early brain development. Disease-causing variants are generally categorised as either loss of function (LoF) or gain of function (GoF) that appear to be linked to different symptoms. Here, we reported a de novo variant (N651D) that has mixed LoF and GoF in a female patient with a devastating developmental and epileptic encephalopathy, parkinsonism and cortical malformation.
View Article and Find Full Text PDF